Aspire Private Capital, LLC Inovio Pharmaceuticals, Inc. Transaction History

Aspire Private Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $716 - $969	100 New	100 $1,000
Q1 2021 May 26, 2021	SELL	$8.81 - $16.96 $881 - $1,696	-100 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $957 - $2,705	100 New	100 $1,000
Q1 2020 May 14, 2020	SELL	$2.98 - $14.09 $298 - $1,409	-100 Closed	0 $0
Q4 2018 Feb 25, 2019	BUY	$3.89 - $6.11 $350 - $549	90 Added 900.0%	100 $0
Q4 2018 Feb 14, 2019	BUY	$3.89 - $6.11 $38 - $61	10 New	10 $0

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $496M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspire Private Capital, LLC with notifications on news.